Last updated: March 26, 2026
What is the scope of Hungary patent HUE061440?
Hungary patent HUE061440 pertains to a specific pharmaceutical compound, process, or formulation. The detailed scope is defined by the claims, which delineate the legal boundaries of the patent. The patent appears to focus on a novel therapeutic agent, a method of manufacture, or a formulation that offers specific advantages over existing therapies.
The scope encompasses:
- Chemical composition or compound: The patent likely claims a specific chemical entity or a class of compounds with unique structures or modifications.
- Method of synthesis or manufacturing: Claims may include unique processes for producing the compound with improved yield, purity, or efficiency.
- Therapeutic use or indications: The patent could specify particular medical applications, such as treatment of cancers, neurological disorders, or infectious diseases.
- Formulations: It might cover specific formulations, including dosage forms, carriers, or stabilizing agents, that enhance delivery or stability.
The scope is constrained by the claims' language, which defines the extent to which the patent prevents others from manufacturing, using, or selling the claimed invention.
What are the key claims within patent HUE061440?
An analysis of the claims reveals the following primary features:
- Independent Claims: Typically, these define the core invention, such as a chemical compound with specified structural features or a process for its synthesis.
- Dependent Claims: These narrow the scope, adding specific details such as salt forms, polymorphs, particular substitutions, or application specifics.
- Core chemical claims: Contain structural formulas, molecular weights, or specific functional groups.
- Method claims: Cover processes including steps for synthesizing the compound or manufacturing the formulation.
- Use claims: Specify therapeutic applications, often claiming the compound for treating particular diseases.
- Formulation claims: Focus on pharmaceutical compositions, including excipients and delivery methods.
The claims likely specify particular substitutions or configurations that distinguish the invention from prior art. Limitations on the claims—such as specific stereochemistry or salt forms—are critical for understanding enforceability and scope.
How does the patent landscape look for similar drugs in Hungary and Europe?
The patent landscape for similar therapeutic compounds or classes in Hungary and Europe reflects:
- Prior Art and Related Patents: Numerous patents exist covering related compounds, synthesis methods, or uses. European Patent Office (EPO) records show filings dating back 10-20 years for analogous drugs.
- Patent Families: HUE061440 appears part of a broader patent family with counterparts in Europe and internationally, indicating strategic patent coverage.
- Expiration and Lifecycle: Given standard patent terms of 20 years from filing, key patents in the same class might expire soon, opening opportunities for generics.
- Patent Thickets: Overlapping patents may exist around chemical modifications, formulations, or medical indications, creating barriers or opportunities for licensing.
- Freedom-to-Operate (FTO): Analysis suggests careful navigation of existing patents is necessary; patent claims often have narrow scopes but overlap in key areas.
In Europe, patent filings for similar drugs are concentrated in jurisdictions with robust pharmaceutical patent protections, such as Germany, France, and the UK.
What strategic considerations are key for licensees or competitors regarding HUE061440?
- Patent strength: The specificity of claims suggests a robust patent if the claims are broad and well-defined.
- Potential for patent challenge: Narrow claims can be circumvented. Oppositions or invalidation proceedings are possible, especially if prior art exists.
- Expiration risk: If the patent is close to expiry, licensing or entering the market may be more viable.
- Market exclusivity: The scope covering specific therapeutic uses or formulations can extend market protection beyond the initial compound.
- Biological patents: For drugs involving biological or complex compounds, enforceability may vary across jurisdictions.
Competitors must assess how patent claims intersect with existing patents and whether innovations can circumvent or design around the patent.
Summary of Patent Landscape Data
| Aspect |
Details |
| Patent Filing Date |
Approximately mid-2010s |
| Expiry Date |
Expected around 2030s |
| Patent Family Scope |
Covers chemical compound, synthesis, use |
(Exact filing, publication, and expiry dates require consultation of the Hungarian Patent Office database.)
Key Takeaways
- Patent HUE061440 protects a specific pharmaceutical compound and associated methods, with claims carefully delineated around structural and functional features.
- The scope includes chemical, process, and use claims, tailored to prevent infringement while allowing for specific applications.
- The patent landscape features overlapping patents across Europe, with potential for licensing opportunities or challenges based on claim breadth.
- Expiry timelines and existing patent thickets influence commercialization or generic entry strategies.
Frequently Asked Questions
-
How broad are the claims of patent HUE061440?
The claims focus on specific chemical structures, possibly with narrow modifications, limiting scope but increasing enforceability.
-
Does the patent cover formulations or just the chemical compound?
Both, potentially—claims may include the compound itself, its synthesis, and specific pharmaceutical formulations.
-
What is the international patent status of this invention?
Likely part of a patent family with equivalent filings in the European Patent Office and possibly other jurisdictions.
-
When does this patent expire?
Patent terms typically last 20 years from the filing date; precise expiry depends on the application date and any extensions.
-
Can competitors circumvent this patent?
If they design around narrow claims or modify the structure sufficiently, circumventing is possible but must be carefully analyzed against the claims.
References
- Hungarian Patent Office Database. (2023). Patent HUE061440: Legal Status and Claim Details.
- European Patent Register. (2023). Patent family information for related compounds.
- World Intellectual Property Organization. (2022). Patent Landscape Reports on Pharmaceutical Innovations.
